EXECUTIVE ENGAGEMENTS
OUTREACH
832
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
166
Interactions with Platform & by Email
PARTICIPANTS
33
Unique # Participated
VALIDATIONS
16
Responses Validated*
* Login for a full stack data experience
DATE
JUL 2020
TABLES
162
PAGES
236
EDITION
6
PRICE
USD $4950
China Has Risen Into An Economic Powerhouse.
Find Out How You Can Leverage This Opportunity!
Amid the COVID-19 crisis, the global market for Renal Biomarker estimated at US$1.1 Billion in the year 2020, is projected to reach a revised size of US$1.6 Billion by 2027, growing at a CAGR of 5.6% over the analysis period 2020-2027. Functional Biomarker, one of the segments analyzed in the report, is projected to record a 6% CAGR and reach US$923.4 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Up-Regulated Protein segment is readjusted to a revised 5.2% CAGR for the next 7-year period.
The Renal Biomarker market in the U.S. is estimated at US$321.7 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$281 Million by the year 2027 trailing a CAGR of 5.2% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.4% and 4.4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.5% CAGR.
In the global Other Biomarkers segment, USA, Canada, Japan, China and Europe will drive the 4.9% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$91.2 Million in the year 2020 will reach a projected size of US$127.8 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$183.4 Million by the year 2027.We bring years of research experience to this 6th edition of our report. The 236-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
SELECT PLAYERS
Abbott Molecular, Inc.; Astute Medical, Inc.; Beckman Coulter, Inc.; BioPorto Diagnostics A/S; Randox Laboratories Ltd.; Thermo Fisher Scientific, Inc.
SEGMENTS
» Biomarker (Functional Biomarker, Up-Regulated Protein, Other Biomarkers) » Diagnostic Technique (Enzyme Linked Immunosorbent Assay, Particle-Enhanced Turbidimetric Immunoassay, Colorimetric Assay, Chemiluminescent Enzyme Immunoassay, Liquid Chromatography-Mass Spectrometry) » End-Use (Diagnostic Labs, Outpatient Clinics, Research Centers, Hospitals)
GEOGRAPHIES
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World
KEY DIFFERENTIATORS
We are firmly committed to build upon perspectives from global executive insights. These engagements enrich our projects. Our primary research programs are fully validated and accessible by clients. (Its a common industry-wide* practice that no validated primary research is done! For the most part, remote resident analysts curate and write reports drawing on search engine research and data modeling.
* A review of 262 off-the-shelf market report publishers worldwide.
WHAT SETS US APART
Client companies can access multiple features on our MarketGlass™ platform.
Clients have full-stack insider access to our ongoing primary research program. We have a very successful incentive driven primary research program that benefits participating executives regardless of their purchase decision. Our platform presents a unique opportunity to collaborate with peers and review competitors’ inputs and response clusters.
Detailed engagement stats are presented for every company and executive contacted. This is made available for our client reviews. (no other publisher offers this!)
A full-stack access to clients of all primary and secondary source content. This can often run into thousands of pages.
Where relevent and possible we present competitive brands.
Peer-to-peer online interactive collaborations. Allows for team curated bespoke analytics.
Customers can update and build bespoke versions of our analytics. Bespoke updates are fulfilled within a two-day turnaround.
Discretely bounce off queries to participant pool of executives. Our embedded AI selectively pings participants geographically and by domain acumen.
We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.
Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.
All updates are offered for one year from date of your purchase without charge. Clients can opt for annual auto renewal and stay current without interruption.
INSIDER ACCESS PRIVILEGES
Users of our portal have insider access to our data stacks based on project relevance and engagement status. Tiered access is offered to data stacks, managed based on user status - Opt-in, Active Panelist, Inactive Panelist, Active Client or Inactive Client.
| I. INTRODUCTION, METHODOLOGY & REPORT SCOPE |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Global Competitor Market Shares |
| Renal Biomarker Competitor Market Share Scenario Worldwide (in %): 2019 & 2025 |
| Impact of Covid-19 and a Looming Global Recession |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| 4. GLOBAL MARKET PERSPECTIVE |
| Renal Biomarker Global Market Estimates and Forecasts in US$ Thousand by Region/Country: 2018-2025 |
| Renal Biomarker Global Retrospective Market Scenario in US$ Thousand by Region/Country: 2009-2017 |
| Renal Biomarker Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025 |
| Enzyme Linked Immunosorbent Assay (Diagnostic Technique) World Market Estimates and Forecasts by Region/Country in US$ Thousand: 2018 to 2025 |
| Enzyme Linked Immunosorbent Assay (Diagnostic Technique) Market Historic Review by Region/Country in US$ Thousand: 2009 to 2017 |
| Enzyme Linked Immunosorbent Assay (Diagnostic Technique) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025 |
| Particle-Enhanced Turbidimetric Immunoassay (Diagnostic Technique) World Market by Region/Country in US$ Thousand: 2018 to 2025 |
| Particle-Enhanced Turbidimetric Immunoassay (Diagnostic Technique) Historic Market Analysis by Region/Country in US$ Thousand: 2009 to 2017 |
| Particle-Enhanced Turbidimetric Immunoassay (Diagnostic Technique) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025 |
| Colorimetric Assay (Diagnostic Technique) World Market Estimates and Forecasts in US$ Thousand by Region/Country: 2018 to 2025 |
| Colorimetric Assay (Diagnostic Technique) Market Worldwide Historic Review by Region/Country in US$ Thousand: 2009 to 2017 |
| Colorimetric Assay (Diagnostic Technique) Market Percentage Share Distribution by Region/Country: 2009 VS 2019 VS 2025 |
| Chemiluminescent Enzyme Immunoassay (Diagnostic Technique) Market Opportunity Analysis Worldwide in US$ Thousand by Region/Country: 2018 to 2025 |
| Chemiluminescent Enzyme Immunoassay (Diagnostic Technique) Global Historic Demand in US$ Thousand by Region/Country: 2009 to 2017 |
| Chemiluminescent Enzyme Immunoassay (Diagnostic Technique) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025 |
| Liquid Chromatography-Mass Spectrometry (Diagnostic Technique) World Market by Region/Country in US$ Thousand: 2018 to 2025 |
| Liquid Chromatography-Mass Spectrometry (Diagnostic Technique) Historic Market Analysis by Region/Country in US$ Thousand: 2009 to 2017 |
| Liquid Chromatography-Mass Spectrometry (Diagnostic Technique) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025 |
| Functional Biomarker (Biomarker) World Market by Region/Country in US$ Thousand: 2018 to 2025 |
| Functional Biomarker (Biomarker) Historic Market Analysis by Region/Country in US$ Thousand: 2009 to 2017 |
| Functional Biomarker (Biomarker) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025 |
| Up-Regulated Protein (Biomarker) Potential Growth Markets Worldwide in US$ Thousand: 2018 to 2025 |
| Up-Regulated Protein (Biomarker) Historic Market Perspective by Region/Country in US$ Thousand: 2009 to 2017 |
| Up-Regulated Protein (Biomarker) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025 |
| Other Biomarkers (Biomarker) Geographic Market Spread Worldwide in US$ Thousand: 2018 to 2025 |
| Other Biomarkers (Biomarker) Region Wise Breakdown of Global Historic Demand in US$ Thousand: 2009 to 2017 |
| Other Biomarkers (Biomarker) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025 |
| Diagnostic Labs (End-Use) Global Market Estimates & Forecasts in US$ Thousand by Region/Country: 2018-2025 |
| Diagnostic Labs (End-Use) Retrospective Demand Analysis in US$ Thousand by Region/Country: 2009-2017 |
| Diagnostic Labs (End-Use) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025 |
| Outpatient Clinics (End-Use) Demand Potential Worldwide in US$ Thousand by Region/Country: 2018-2025 |
| Outpatient Clinics (End-Use) Historic Sales Analysis in US$ Thousand by Region/Country: 2009-2017 |
| Outpatient Clinics (End-Use) Share Breakdown Review by Region/Country: 2009 VS 2019 VS 2025 |
| Research Centers (End-Use) Worldwide Latent Demand Forecasts in US$ Thousand by Region/Country: 2018-2025 |
| Research Centers (End-Use) Global Historic Analysis in US$ Thousand by Region/Country: 2009-2017 |
| Research Centers (End-Use) Distribution of Global Sales by Region/Country: 2009 VS 2019 VS 2025 |
| Hospitals (End-Use) Sales Estimates and Forecasts in US$ Thousand by Region/Country for the Years 2018 through 2025 |
| Hospitals (End-Use) Analysis of Historic Sales in US$ Thousand by Region/Country for the Years 2009 to 2017 |
| Hospitals (End-Use) Global Market Share Distribution by Region/Country for 2009, 2019, and 2025 |
| III. MARKET ANALYSIS |
| GEOGRAPHIC MARKET ANALYSIS |
| UNITED STATES |
| Market Facts & Figures |
| US Renal Biomarker Market Share (in %) by Company: 2019 & 2025 |
| United States Renal Biomarker Market Estimates and Projections in US$ Thousand by Diagnostic Technique: 2018 to 2025 |
| Renal Biomarker Market in the United States by Diagnostic Technique: A Historic Review in US$ Thousand for 2009-2017 |
| United States Renal Biomarker Market Share Breakdown by Diagnostic Technique: 2009 VS 2019 VS 2025 |
| United States Renal Biomarker Market Estimates and Projections in US$ Thousand by Biomarker: 2018 to 2025 |
| Renal Biomarker Market in the United States by Biomarker: A Historic Review in US$ Thousand for 2009-2017 |
| United States Renal Biomarker Market Share Breakdown by Biomarker: 2009 VS 2019 VS 2025 |
| United States Renal Biomarker Latent Demand Forecasts in US$ Thousand by End-Use: 2018 to 2025 |
| Renal Biomarker Historic Demand Patterns in the United States by End-Use in US$ Thousand for 2009-2017 |
| Renal Biomarker Market Share Breakdown in the United States by End-Use: 2009 VS 2019 VS 2025 |
| CANADA |
| Canadian Renal Biomarker Market Estimates and Forecasts in US$ Thousand by Diagnostic Technique: 2018 to 2025 |
| Canadian Renal Biomarker Historic Market Review by Diagnostic Technique in US$ Thousand: 2009-2017 |
| Renal Biomarker Market in Canada: Percentage Share Breakdown of Sales by Diagnostic Technique for 2009, 2019, and 2025 |
| Canadian Renal Biomarker Market Estimates and Forecasts in US$ Thousand by Biomarker: 2018 to 2025 |
| Canadian Renal Biomarker Historic Market Review by Biomarker in US$ Thousand: 2009-2017 |
| Renal Biomarker Market in Canada: Percentage Share Breakdown of Sales by Biomarker for 2009, 2019, and 2025 |
| Canadian Renal Biomarker Market Quantitative Demand Analysis in US$ Thousand by End-Use: 2018 to 2025 |
| Renal Biomarker Market in Canada: Summarization of Historic Demand Patterns in US$ Thousand by End-Use for 2009-2017 |
| Canadian Renal Biomarker Market Share Analysis by End-Use: 2009 VS 2019 VS 2025 |
| JAPAN |
| Japanese Market for Renal Biomarker: Annual Sales Estimates and Projections in US$ Thousand by Diagnostic Technique for the Period 2018-2025 |
| Renal Biomarker Market in Japan: Historic Sales Analysis in US$ Thousand by Diagnostic Technique for the Period 2009-2017 |
| Japanese Renal Biomarker Market Share Analysis by Diagnostic Technique: 2009 VS 2019 VS 2025 |
| Japanese Market for Renal Biomarker: Annual Sales Estimates and Projections in US$ Thousand by Biomarker for the Period 2018-2025 |
| Renal Biomarker Market in Japan: Historic Sales Analysis in US$ Thousand by Biomarker for the Period 2009-2017 |
| Japanese Renal Biomarker Market Share Analysis by Biomarker: 2009 VS 2019 VS 2025 |
| Japanese Demand Estimates and Forecasts for Renal Biomarker in US$ Thousand by End-Use: 2018 to 2025 |
| Japanese Renal Biomarker Market in US$ Thousand by End-Use: 2009-2017 |
| Renal Biomarker Market Share Shift in Japan by End-Use: 2009 VS 2019 VS 2025 |
| CHINA |
| Chinese Renal Biomarker Market Growth Prospects in US$ Thousand by Diagnostic Technique for the Period 2018-2025 |
| Renal Biomarker Historic Market Analysis in China in US$ Thousand by Diagnostic Technique: 2009-2017 |
| Chinese Renal Biomarker Market by Diagnostic Technique: Percentage Breakdown of Sales for 2009, 2019, and 2025 |
| Chinese Renal Biomarker Market Growth Prospects in US$ Thousand by Biomarker for the Period 2018-2025 |
| Renal Biomarker Historic Market Analysis in China in US$ Thousand by Biomarker: 2009-2017 |
| Chinese Renal Biomarker Market by Biomarker: Percentage Breakdown of Sales for 2009, 2019, and 2025 |
| Chinese Demand for Renal Biomarker in US$ Thousand by End-Use: 2018 to 2025 |
| Renal Biomarker Market Review in China in US$ Thousand by End-Use: 2009-2017 |
| Chinese Renal Biomarker Market Share Breakdown by End-Use: 2009 VS 2019 VS 2025 |
| EUROPE |
| Market Facts & Figures |
| European Renal Biomarker Market: Competitor Market Share Scenario (in %) for 2019 & 2025 |
| European Renal Biomarker Market Demand Scenario in US$ Thousand by Region/Country: 2018-2025 |
| Renal Biomarker Market in Europe: A Historic Market Perspective in US$ Thousand by Region/Country for the Period 2009-2017 |
| European Renal Biomarker Market Share Shift by Region/Country: 2009 VS 2019 VS 2025 |
| European Renal Biomarker Market Estimates and Forecasts in US$ Thousand by Diagnostic Technique: 2018-2025 |
| Renal Biomarker Market in Europe in US$ Thousand by Diagnostic Technique: A Historic Review for the Period 2009-2017 |
| European Renal Biomarker Market Share Breakdown by Diagnostic Technique: 2009 VS 2019 VS 2025 |
| European Renal Biomarker Market Estimates and Forecasts in US$ Thousand by Biomarker: 2018-2025 |
| Renal Biomarker Market in Europe in US$ Thousand by Biomarker: A Historic Review for the Period 2009-2017 |
| European Renal Biomarker Market Share Breakdown by Biomarker: 2009 VS 2019 VS 2025 |
| European Renal Biomarker Addressable Market Opportunity in US$ Thousand by End-Use: 2018-2025 |
| Renal Biomarker Market in Europe: Summarization of Historic Demand in US$ Thousand by End-Use for the Period 2009-2017 |
| European Renal Biomarker Market Share Analysis by End-Use: 2009 VS 2019 VS 2025 |
| FRANCE |
| Renal Biomarker Market in France by Diagnostic Technique: Estimates and Projections in US$ Thousand for the Period 2018-2025 |
| French Renal Biomarker Historic Market Scenario in US$ Thousand by Diagnostic Technique: 2009-2017 |
| French Renal Biomarker Market Share Analysis by Diagnostic Technique: 2009 VS 2019 VS 2025 |
| Renal Biomarker Market in France by Biomarker: Estimates and Projections in US$ Thousand for the Period 2018-2025 |
| French Renal Biomarker Historic Market Scenario in US$ Thousand by Biomarker: 2009-2017 |
| French Renal Biomarker Market Share Analysis by Biomarker: 2009 VS 2019 VS 2025 |
| Renal Biomarker Quantitative Demand Analysis in France in US$ Thousand by End-Use: 2018-2025 |
| French Renal Biomarker Historic Market Review in US$ Thousand by End-Use: 2009-2017 |
| French Renal Biomarker Market Share Analysis: A 17-Year Perspective by End-Use for 2009, 2019, and 2025 |
| GERMANY |
| Renal Biomarker Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Diagnostic Technique for the Period 2018-2025 |
| German Renal Biomarker Historic Market Analysis in US$ Thousand by Diagnostic Technique: 2009-2017 |
| German Renal Biomarker Market Share Breakdown by Diagnostic Technique: 2009 VS 2019 VS 2025 |
| Renal Biomarker Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Biomarker for the Period 2018-2025 |
| German Renal Biomarker Historic Market Analysis in US$ Thousand by Biomarker: 2009-2017 |
| German Renal Biomarker Market Share Breakdown by Biomarker: 2009 VS 2019 VS 2025 |
| Renal Biomarker Market in Germany: Annual Sales Estimates and Forecasts in US$ Thousand by End-Use for the Period 2018-2025 |
| German Renal Biomarker Market in Retrospect in US$ Thousand by End-Use: 2009-2017 |
| Renal Biomarker Market Share Distribution in Germany by End-Use: 2009 VS 2019 VS 2025 |
| ITALY |
| Italian Renal Biomarker Market Growth Prospects in US$ Thousand by Diagnostic Technique for the Period 2018-2025 |
| Renal Biomarker Historic Market Analysis in Italy in US$ Thousand by Diagnostic Technique: 2009-2017 |
| Italian Renal Biomarker Market by Diagnostic Technique: Percentage Breakdown of Sales for 2009, 2019, and 2025 |
| Italian Renal Biomarker Market Growth Prospects in US$ Thousand by Biomarker for the Period 2018-2025 |
| Renal Biomarker Historic Market Analysis in Italy in US$ Thousand by Biomarker: 2009-2017 |
| Italian Renal Biomarker Market by Biomarker: Percentage Breakdown of Sales for 2009, 2019, and 2025 |
| Italian Demand for Renal Biomarker in US$ Thousand by End-Use: 2018 to 2025 |
| Renal Biomarker Market Review in Italy in US$ Thousand by End-Use: 2009-2017 |
| Italian Renal Biomarker Market Share Breakdown by End-Use: 2009 VS 2019 VS 2025 |
| UNITED KINGDOM |
| United Kingdom Market for Renal Biomarker: Annual Sales Estimates and Projections in US$ Thousand by Diagnostic Technique for the Period 2018-2025 |
| Renal Biomarker Market in the United Kingdom: Historic Sales Analysis in US$ Thousand by Diagnostic Technique for the Period 2009-2017 |
| United Kingdom Renal Biomarker Market Share Analysis by Diagnostic Technique: 2009 VS 2019 VS 2025 |
| United Kingdom Market for Renal Biomarker: Annual Sales Estimates and Projections in US$ Thousand by Biomarker for the Period 2018-2025 |
| Renal Biomarker Market in the United Kingdom: Historic Sales Analysis in US$ Thousand by Biomarker for the Period 2009-2017 |
| United Kingdom Renal Biomarker Market Share Analysis by Biomarker: 2009 VS 2019 VS 2025 |
| United Kingdom Demand Estimates and Forecasts for Renal Biomarker in US$ Thousand by End-Use: 2018 to 2025 |
| United Kingdom Renal Biomarker Market in US$ Thousand by End-Use: 2009-2017 |
| Renal Biomarker Market Share Shift in the United Kingdom by End-Use: 2009 VS 2019 VS 2025 |
| REST OF EUROPE |
| Rest of Europe Renal Biomarker Market Estimates and Forecasts in US$ Thousand by Diagnostic Technique: 2018-2025 |
| Renal Biomarker Market in Rest of Europe in US$ Thousand by Diagnostic Technique: A Historic Review for the Period 2009-2017 |
| Rest of Europe Renal Biomarker Market Share Breakdown by Diagnostic Technique: 2009 VS 2019 VS 2025 |
| Rest of Europe Renal Biomarker Market Estimates and Forecasts in US$ Thousand by Biomarker: 2018-2025 |
| Renal Biomarker Market in Rest of Europe in US$ Thousand by Biomarker: A Historic Review for the Period 2009-2017 |
| Rest of Europe Renal Biomarker Market Share Breakdown by Biomarker: 2009 VS 2019 VS 2025 |
| Rest of Europe Renal Biomarker Addressable Market Opportunity in US$ Thousand by End-Use: 2018-2025 |
| Renal Biomarker Market in Rest of Europe: Summarization of Historic Demand in US$ Thousand by End-Use for the Period 2009-2017 |
| Rest of Europe Renal Biomarker Market Share Analysis by End-Use: 2009 VS 2019 VS 2025 |
| ASIA-PACIFIC |
| Renal Biomarker Market in Asia-Pacific by Diagnostic Technique: Estimates and Projections in US$ Thousand for the Period 2018-2025 |
| Asia-Pacific Renal Biomarker Historic Market Scenario in US$ Thousand by Diagnostic Technique: 2009-2017 |
| Asia-Pacific Renal Biomarker Market Share Analysis by Diagnostic Technique: 2009 VS 2019 VS 2025 |
| Renal Biomarker Market in Asia-Pacific by Biomarker: Estimates and Projections in US$ Thousand for the Period 2018-2025 |
| Asia-Pacific Renal Biomarker Historic Market Scenario in US$ Thousand by Biomarker: 2009-2017 |
| Asia-Pacific Renal Biomarker Market Share Analysis by Biomarker: 2009 VS 2019 VS 2025 |
| Renal Biomarker Quantitative Demand Analysis in Asia-Pacific in US$ Thousand by End-Use: 2018-2025 |
| Asia-Pacific Renal Biomarker Historic Market Review in US$ Thousand by End-Use: 2009-2017 |
| Asia-Pacific Renal Biomarker Market Share Analysis: A 17-Year Perspective by End-Use for 2009, 2019, and 2025 |
| REST OF WORLD |
| Rest of World Renal Biomarker Market Estimates and Forecasts in US$ Thousand by Diagnostic Technique: 2018 to 2025 |
| Rest of World Renal Biomarker Historic Market Review by Diagnostic Technique in US$ Thousand: 2009-2017 |
| Renal Biomarker Market in Rest of World: Percentage Share Breakdown of Sales by Diagnostic Technique for 2009, 2019, and 2025 |
| Rest of World Renal Biomarker Market Estimates and Forecasts in US$ Thousand by Biomarker: 2018 to 2025 |
| Rest of World Renal Biomarker Historic Market Review by Biomarker in US$ Thousand: 2009-2017 |
| Renal Biomarker Market in Rest of World: Percentage Share Breakdown of Sales by Biomarker for 2009, 2019, and 2025 |
| Rest of World Renal Biomarker Market Quantitative Demand Analysis in US$ Thousand by End-Use: 2018 to 2025 |
| Renal Biomarker Market in Rest of World: Summarization of Historic Demand Patterns in US$ Thousand by End-Use for 2009-2017 |
| Rest of World Renal Biomarker Market Share Analysis by End-Use: 2009 VS 2019 VS 2025 |
| IV. COMPETITION |
| Total Companies Profiled : 44 Click here to request a full table of contents and more details on this project. |
| V. CURATED RESEARCH |
KEY DIFFERENTIATORS
We are firmly committed to build upon perspectives from global executive insights. These engagements enrich our projects. Our primary research programs are fully validated and accessible by clients. (Its a common industry-wide* practice that no validated primary research is done! For the most part, remote resident analysts curate and write reports drawing on search engine research and data modeling.
* A review of 262 off-the-shelf market report publishers worldwide.
WHAT SETS US APART
Client companies can access multiple features on our MarketGlass™ platform.
Clients have full-stack insider access to our ongoing primary research program. We have a very successful incentive driven primary research program that benefits participating executives regardless of their purchase decision. Our platform presents a unique opportunity to collaborate with peers and review competitors’ inputs and response clusters.
Detailed engagement stats are presented for every company and executive contacted. This is made available for our client reviews. (no other publisher offers this!)
A full-stack access to clients of all primary and secondary source content. This can often run into thousands of pages.
Where relevent and possible we present competitive brands.
Peer-to-peer online interactive collaborations. Allows for team curated bespoke analytics.
Customers can update and build bespoke versions of our analytics. Bespoke updates are fulfilled within a two-day turnaround.
Discretely bounce off queries to participant pool of executives. Our embedded AI selectively pings participants geographically and by domain acumen.
We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.
Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.
All updates are offered for one year from date of your purchase without charge. Clients can opt for annual auto renewal and stay current without interruption.
RESEARCH PANEL
Panelists are carefully chosen based on their domain expertise and market influence.
Participation in our expert panels is only by invitation. Our project focused panels are constituted of senior executives in business strategy, marketing, sales, and product management at competitive companies worldwide. We also welcome individuals from leading management consulting, venture capital, private equity, investment management and related firms with domain expertise and are actively monitoring specific companies or industries. Our panelists bring unique market perspectives and unbiased intelligence to our ongoing research programs.
Our panelists give 30-minutes a month or a one-time 30-minute participation based on their time and willingness.
- Complimentary previews of full stack research data for participated
- Insider access to research programs including engagements and stats from other panelists
- Unlimited research credits of $1000 per participated project
- Competitive Intelligence Alerts including engagements from other panelists and validated participants worldwide relevant to your company
- Interact with other panelists via our MarketGlassTM Data Exchange Platform*
- BlogX - Panelists can use our blogging platform publish their viewpoints on news relevant to their domain expertise. Platform enables panelists to share their viewpoints on current news and events related to their areas domain expertise with timely and insightful blogs*
* Complete details will be shared with panelists upon formal acceptance.